Skip to main content

What the FDA labels say about taking them together

Atropine/diphenoxylate and meperidine

Atropine/diphenoxylate's FDA label of February 23, 2026 names meperidine in its warnings section; the meperidine labels PlainMeds reads (2) do not name atropine/diphenoxylate.

Check it at the source: the atropine/diphenoxylate FDA label on DailyMed (effective February 23, 2026, Pfizer Laboratories Div Pfizer Inc); the meperidine FDA label on DailyMed (effective November 29, 2025, EPIC PHARMA, LLC).

What does the atropine/diphenoxylate label say about meperidine?

Atropine/diphenoxylate label, warnings

Interaction with Meperidine Hydrocholoride Since the chemical structure of diphenoxylate hydrochloride is similar to that of meperidine hydrochloride, the concurrent use of Lomotil with monoamine oxidase (MAO) inhibitors may, in theory, precipitate hypertensive crisis.

Source: FDA drug label (Lomotil), Pfizer Laboratories Div Pfizer Inc, effective February 23, 2026 (SPL set f170584a-1072-4fd7-b1dc-6756703483b9), via openFDA; the full label on DailyMed

What does the meperidine label say about atropine/diphenoxylate?

Meperidine's label (effective November 29, 2025) and its 1 other brand-application label do not name atropine/diphenoxylate in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Meperidine Hydrochloride), EPIC PHARMA, LLC, effective November 29, 2025 (SPL set fae5cc34-5917-4445-9516-25f97ffca8db), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

19Atropine/diphenoxylate generic labelers
3Meperidine generic labelers
Atropine/diphenoxylateMeperidine
Labeled forDiarrheaPain
Boxed warningNoYes
Pharmacy cost (NADAC)$0.139 per tablet 2.5-0.025 mg tablet$0.157 per mL 50 mg/5 mL solution
Shortage nowNo current entryListed; available

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?